Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

26.37
Delayed Data
As of Apr 21
 -0.59 / -2.19%
Today’s Change
8.16
Today|||52-Week Range
29.41
+38.64%
Year-to-Date
No recent news for Flexion Therapeutics Inc.

Today’s Trading

Previous close26.96
Today’s open26.96
Day’s range26.15 - 27.00
Volume322,925
Average volume (3 months)435,836
Market cap$836.8M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-32.09%
Earnings growth (this year)-20.46%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.46

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-0.69-1.85%
HRTXHeron Therapeutics I...-0.50-3.18%
CLLSCellectis SA-0.35-1.52%
AKAOAchaogen Inc-0.21-0.94%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$0.00
Annual profit (last year)-$71.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Michael D. Clayman
Senior Vice President-
CMC Operations
Dan Leblanc
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs